Thursday, May 09, 2024 1:55:12 PM
While I was trying to take a look at one of Oncovir's partners, I found this French company called LinkinVax, the interesting part is that the founder of the company is Levy Yves who did plenty research on CYT107. He also happened to be the program coordinator for the research project by the Vaccine Research Institute. Seems like they are all connected in some way. Just something fun to share.
A platform of vaccine candidates has been developed within VRI (Lipopeptides, DC based vaccines, Pox virus (MVA)) or in collaboration: NYVAC (CHUV, Eurovacc, Sanofi Pasteur), DNA (Eurovacc, Fit Biotech), new flavivirus (Replivax vector Sanofi Pasteur), Ad26/MVA Ebola (Janssen), VSV Ebola (Merck) & adjuvant/immunomodulators: Poly-ICLC (Oncovir), GLA (AAHI), IL-7 (Cytheris, Revimmune). In the last twelve years, several HIV programs have been moved from preclinical to phase I/II clinical trials (Light, VRI01&06, EHVAP01).
https://linkinvax.com/about-us-aids-vaccine-laboratory-linkinvax/
https://scholar.google.com/scholar?hl=en&as_sdt=0%2C44&q=Yves+Levy++%2B+CYT107&btnG=
Recent NWBO News
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
